The effects of resistance training on ApoB/ApoA-I ratio, Lp(a) and inflammatory markers in patients with type 2 diabetes

被引:50
作者
Kadoglou, Nikolaos P. E. [1 ,2 ]
Fotiadis, Grigorios [2 ]
Athanasiadou, Zoi [2 ]
Vitta, Ioulia [2 ]
Lampropoulos, Stylianos [3 ]
Vrabas, Ioannis S. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Phys Educ & Sports Sci, Ag Ioannis 62110, Serres, Greece
[2] Hippokrateion Hosp, Dept Internal Med 1, Thessaloniki, Greece
[3] Bodosakio Gen Hosp Ptolemaida, Dept Cardiol, Ptolemaida, Greece
关键词
Type; 2; diabetes; Resistance training; Exercise; Insulin resistance; Apolipoprotein A-I; Apolipoprotein B; Lp(a); hsCRP; CARDIOVASCULAR RISK-FACTORS; APOLIPOPROTEIN-A-I; EXERCISE; MELLITUS; LIPOPROTEIN(A); METAANALYSIS; INTERVENTION; ASSOCIATION; PREVENTION; BENEFITS;
D O I
10.1007/s12020-012-9650-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to investigate the effects of resistance training (RT) on novel cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM). We enrolled 52 overweight/obese, type 2 diabetic patients, with inadequate glycemic control (HbA1c > 6.5 %), but without overt diabetic vascular complications. Participants were randomly assigned into two equivalent groups (n = 26): (1) Resistance exercise group: subjects underwent a supervised RT program (3-times/week, 60 min/session, 2-3 sets of 8 machine-weight exercises, 60-80 % of one-repetition maximum). (2) Control group (CG): at study entrance, they received a structured exercise counseling to increase daily physical activity. Clinical parameters, cardiorespiratory capacity, glycemic and lipid profile, apolipoprotein A-I (ApoA-I), apolipoprotein B (ApoB), Lipoprotein(a) [Lp(a)], insulin resistance (HOMA-IR), high-sensitivity CRP (hsCRP), fibrinogen were measured before and after 3 months. RT significantly reduced glycemic indexes, insulin resistance and systolic blood pressure, compared to CG (p < 0.05). Moreover, exercise-treated patients conferred a remarkable downregulation in ApoB levels (from 135.92 +/- A 30.97 mg/dL to 85.9 +/- A 26.46 mg/dL, p < 0.001) as compared to CG (from 126.33 +/- A 36.59 mg/dL to 116.23 +/- A 27.52 mg/dL, p = 0.872) (p < 0.001). Similarly, ApoB/ApoA-I ratio was considerably decreased in REG rather than CG (-0.32 +/- A 0.09 vs 0.02 +/- A 0.01, p < 0.001). Notably, ApoA-I, Lp(a), hsCRP, fibrinogen, the rest of lipid parameters, body weight and exercise capacity remained unaltered in both groups (p > 0.05). Among variables, HOMA-IR reduction was found to be an independent predictor of changes in ApoB/ApoA-I ratio (R (2) = 0.406, p = 0.041) in REG. Long-term RT ameliorated glycemic control, insulin sensitivity and ApoB/ApoA-I ratio in individuals with T2DM. Although we did not observe significant benefits in the rest of cardiovascular risk factors, our results indicate a merely beneficial impact of RT.
引用
收藏
页码:561 / 569
页数:9
相关论文
共 50 条
[21]   Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs-apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes [J].
Niemi, Jaakko ;
Makinen, Ville-Petteri ;
Heikkonen, Jukka ;
Tenkanen, Leena ;
Hiltunen, Yrjo ;
Hannuksela, Minna L. ;
Jauhiainen, Matti ;
Forsblom, Carol ;
Taskinen, Marja-Riitta ;
Kesaniemi, Y. Antero ;
Savolainen, Markku J. ;
Kaski, Kimmo ;
Groop, Per-Henrik ;
Kovanen, Petri T. ;
Ala-Korpela, Mika .
ANNALS OF MEDICINE, 2009, 41 (06) :451-U69
[22]   The Effects of Berberis vulgaris Fruit Extract on Serum Lipoproteins, apoB, apoA-I, Homocysteine, Glycemic Control and Total Antioxidant Capacity in Type 2 Diabetic Patients [J].
Shidfar, Farzad ;
Ebrahimi, Shima Seyyed ;
Hosseini, Sharieh ;
Heydari, Iraj ;
Shidfar, Shahrzad ;
Hajhassani, Giti .
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2012, 11 (02) :643-652
[23]   Effects of exercise training on mitochondrial function in patients with type 2 diabetes [J].
Larsen, Steen ;
Skaaby, Stinna ;
Helge, Jorn W. ;
Dela, Flemming .
WORLD JOURNAL OF DIABETES, 2014, 5 (04) :482-492
[24]   Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension [J].
Park, Hyohun ;
Hasegawa, Goji ;
Obayashi, Hiroshi ;
Fujinami, Aya ;
Ohta, Mitsuhiro ;
Hara, Hirokazu ;
Adachi, Tetsuo ;
Tamaki, Shoko ;
Nakajima, Yoshiki ;
Kimura, Fumiaki ;
Ogata, Masakazu ;
Fukui, Michiaki ;
Yoshikawa, Toshikazu ;
Nakamura, Naoto .
CLINICA CHIMICA ACTA, 2006, 374 (1-2) :129-134
[25]   Increased apoB/A-I ratio independently associated with Type 2 diabetes mellitus: cross-sectional study in a Korean population [J].
Hwang, Y. C. ;
Ahn, H. Y. ;
Kim, W. J. ;
Park, C. Y. ;
Park, S. W. .
DIABETIC MEDICINE, 2012, 29 (09) :1165-1170
[26]   Effects of resistance training using elastic bands on muscle strength with or without a leucine supplement for 48 weeks in elderly patients with type 2 diabetes [J].
Yamamoto, Yutaro ;
Nagai, Yoshio ;
Kawanabe, Shin ;
Hishida, Yoshiaki ;
Hiraki, Koji ;
Sone, Masakatsu ;
Tanaka, Yasushi .
ENDOCRINE JOURNAL, 2021, 68 (03) :291-298
[27]   HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial [J].
Blanco-Rojo, Ruth ;
Perez-Martinez, Pablo ;
Lopez-Moreno, Javier ;
Martinez-Botas, Javier ;
Delgado-Lista, Javier ;
Van-Ommen, Ben ;
Yubero-Serrano, Elena ;
Camargo, Antonio ;
Ordovas, Jose M. ;
Perez-Jimenez, Francisco ;
Gomez-Coronado, Diego ;
Lopez-Miranda, Jose .
SCIENTIFIC REPORTS, 2017, 7
[28]   The Effect of Sumac Rhuscoriaria L. Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients [J].
Shidfar, Farzad ;
Rahideh, Seyedeh Tayebeh ;
Rajab, Asadollah ;
Khandozi, Nafise ;
Hosseini, Sharieh ;
Shidfar, Shahrzad ;
Mojab, Faraz .
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (04) :1249-1255
[29]   HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes [J].
Waldman, Boris ;
Jenkins, Alicia J. ;
Davis, Timothy M. E. ;
Taskinen, Marja-Riitta ;
Scott, Russell ;
O'Connell, Rachel L. ;
Gebski, Val J. ;
Ng, Martin K. C. ;
Keech, Anthony C. .
DIABETES CARE, 2014, 37 (08) :2351-2358
[30]   Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes [J].
Chilton, R. ;
Tikkanen, I. ;
Cannon, C. P. ;
Crowe, S. ;
Woerle, H. J. ;
Broedl, U. C. ;
Johansen, O. E. .
DIABETES OBESITY & METABOLISM, 2015, 17 (12) :1180-1193